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TUNEL-positive (72%) showed moderate to low levels of
TNF- and nitrotyrosine levels. Moreover, by multivariate
analysis, HbA1c was independently related to VSMC apopto-
sis, as showed by TUNEL-positive VSMCs and caspase-3
levels (p  0.030 and p  0.026, respectively).
Our study shows that VSMC apoptosis may be involved in
the evolution of diabetic plaques toward instability. In partic-
ular, VSMC apoptosis is greater in diabetic lesions than
nondiabetic lesions and was associated with higher TNF- and
IL-1 levels along with lower interstitial collagen and -SMC
actin content. All this would make diabetic plaques more prone
to inflammatory-dependent rupture and might increase the risk
of cerebrovascular ischemic events (7,8). In our study, macro-
phages were more abundant in diabetic plaques and represented the
major source of inflammatory cytokines, suggesting the presence of an
active inflammatory reaction in diabetic plaques. In agreement with
the difference in apoptosis staining pattern, the histologic milieu of
the lesions appears different with regard to cellularity, but not in
the degree of vessel stenosis, suggesting that diabetic and nondi-
abetic lesions are different only with regard to inflammatory
burden. Hence, the differences in plaque behavior likely stem from
differences in the presence of stimuli (i.e., persistent hyperglycemia
and oxidative stress, as evidenced by high HbA1c and nitrotyrosine
levels) for selective expression of TNF- or IL-1 capable of
disrupting plaque stability via VSMC apoptosis. Notably, the intrigu-
ing and novel proatherogenic mechanism of apoptosis in human
diabetes is supported in this study not only by the observation that
VSMC apoptosis is higher in diabetic plaques, but also by the
information that it is strongly correlated with the intensity of
glycemic control as reflected by HbA1c. The mechanism of the
relationship of cytokines with the VSMC apoptotic process re-
mains uncertain in diabetic plaques. However, TNF- and IL-1
do not act in isolation, as macrophage-induced VSMC apoptosis
through formation of peroxynitrite also requires nitric oxide and
oxygen free radicals (9). This suggests that cooperative interactions
might occur between these mediators, and the present study
outlines such associations demonstrating a presence of overpro-
duction of nitrotyrosine, a good marker of peroxynitrite formation
(10), in diabetic plaques that was not present in nondiabetic
lesions. Indeed, these stimuli of diabetic milieu can also induce
apoptosis of endothelial cells, resulting in vascular leak and
inflammation, which are implicated in the pathogenesis of vascular
diseases (3). This study demonstrates enhanced VSMC apoptosis
in diabetic carotid atherosclerotic lesions and provides evidence
that the activation of this mechanism by inflammatory cells is
associated with an increase in oxidative stress potentially promoting
plaque rupture. These findings are potentially important from a
fundamental standpoint, because they indicate a pathogenetic role for
the VSMC apoptosis in the evolution of diabetic atherosclerotic
lesions. From a practical standpoint, these findings provide further
support for the role of glycemic control on plaque stabilization in
diabetic patients with atherosclerotic disease.
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Evidence of Cocaine-Related Coronary Atherosclerosis in Young Patients
With Myocardial Infarction
To the Editor: Cocaine use has increased in the last years reaching
in 1999 in the U.S. 30% of all drug-related visits to the emergency
department, exceeding morphine and representing the most fre-
quent cause of drug-related deaths (1). One of every four myocar-
dial infarctions (MIs) in people aged 18 to 45 years can be linked
to cocaine use (2). Several reports (3) implicated coronary vaso-
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spasm in normal coronary arteries as the cause of MI in cocaine
users, but other studies revealed the cocaine-related enhanced
vasoconstriction at the site of significant stenosis (4). Animal and
experimental studies support the proatherosclerotic effects of
cocaine (5); this drug may increase concentration of plasminogen-
activator inhibitor, endothelial permeability to low-density lipopro-
tein, and platelet activation and aggregability. Moreover, post-
mortem studies have suggested that signs of coronary atherosclerosis
can be detected in cocaine users, despite the young age (6), but this
observation can be influenced by survival bias. Thus, we studied the
prevalence of coronary atherosclerosis in young patients suffering from
acute MI with and without evidence of cocaine use.
We enrolled 51 consecutive Caucasian patients (49 men) with
MI with persistent ST-segment elevation (STEMI), as first
manifestation of coronary artery disease (CAD), age 50 years. A
total of 17 patients (16 men) reported non-occasional cocaine use.
We excluded from the study occasional cocaine users. No temporal
relationship between cocaine use and onset of acute MI was
considered among the inclusion criteria, but only a self-reported
history of non-occasional use of cocaine. As previously reported
(2), regular user was defined as having experienced cocaine in
lifetime 10 to 100 times or100 times, occasional user10 times.
In our study, by angiography, we compared the extent of coronary
atherosclerosis in cocaine users versus non-cocaine users with
STEMI. We also assessed the number of common risk factors
(family history, smoking, overweight, hypertension, diabetes, dyslip-
idemia) and the acute cardiovascular risk profile by Thrombolysis In
Myocardial Infarction risk score (TRS). Coronary angiography
was performed according to standard techniques and angiograms
reviewed according to the American College of Cardiology/
American Heart Association classification. A semiquantitative
assay for the primary urinary metabolite of cocaine, benzoylecgo-
nine, was carried out in all patients (Cozart, Oxfordshire, United
Kingdom). Data are presented as mean  SD. Differences be-
tween groups were always tested with non-parametric statistics,
thus avoiding the need for normalization or transformation of data.
Continuous variables were compared with Mann-Whitney U test,
while frequencies were compared with Fisher exact test. A p value
of 0.05 (two-tailed) was considered as significant.
As compared with the control group, the cocaine users had
lower mean age (38.8  5.8 vs. 43.9  3.7, p  0.01), lower mean
number of CAD risk factors (1.4/patient vs. 2.1/patient, p 0.05),
and lower incidence of patients with multiple risk factors (29% vs.
85%, p  0.01). Cocaine users had also a lower TRS on admission
(TRS 3, 18% vs. 56%, p  0.01). Seven patients (41%), with
positive urinary test, had used cocaine in the 24 h before MI. The
prevalence of non-significant coronary atherosclerosis was quite
low and similar in both groups (12% vs. 9%, p  NS). The
prevalence of at least one critical coronary stenosis (70%) was
also similar in the two groups (76% vs. 70%, p  NS). However,
cocaine users had a higher prevalence of multivessel disease (65%
vs. 32%, p  0.05) and a higher number of coronary artery lesions
50% (2.3/patient vs. 1.6/patient, p  0.05) (Fig. 1). There were
no significant differences in the acute MI treatment (thrombolysis
65% vs. 85%, pNS; primary PTCA 6% vs. 15%, pNS; rescue
PTCA 18% vs. 24%, p  NS), in the overall rate of coronary
revascularization procedures (PTCA 59% vs. 73%, p  NS;
coronary artery bypass graft 24% vs. 18%, p  NS), and in the MI
culprit vessel (left anterior descending 53% vs. 44%, p  NS;
circumflex 18% vs. 21%, p NS; right 18% vs. 26%, p NS). No
patient died during the hospitalization. No intracranial bleeding
was observed, despite the frequent use of thrombolytic therapy in
a class of patients considered to have a high hemorrhagic risk, due
to hypertensive surge and cerebral vasospasm (7). No patient in the
control group had a positive urinary test.
This is the first study that compares the prevalence of coronary
atherosclerosis in young patients with STEMI with and without
history of cocaine use. We found that significant coronary athero-
sclerosis is quite common in cocaine users with MI, and can even
be more severe and diffuse than in non-cocaine users, even with a
more benign risk factor profile.
Cocaine induces vasoconstriction primarily by blocking the
pre-synaptic reuptake of norepinephrine and by stimulating alpha-
adrenergic receptors; thus, it has been suggested that coronary
spasm on otherwise normal coronary arteries may be the main
cause of MI in young cocaine users (3). However, only a direct
comparison of prevalence of coronary atherosclerosis between
cocaine and non-cocaine users, in the same population of young
patients with STEMI, as in our study, could support this hypoth-
esis. On the contrary, our findings support the hypothesis that in
cocaine users functional factors (including coronary spasm) occur
in a significant atherosclerotic background.
In our study, we did not assess the relationship between the
duration and frequency of cocaine use and the extent of CAD,
because of the limited size of the population. We found that only
41% of the cocaine users had a positive drug urinary test. We did
not focus on the immediate causal relationship between cocaine
use and onset of MI, but on the relationship between chronic use
of cocaine and acceleration of atherosclerosis. The urinary drug
screening test was mainly performed to check the patients of the
control group, who denied cocaine use in the previous 24 h.
Another limit is represented by the fact that low social status
(which may be more common in cocaine users) is also an
independent CAD risk factor (8), but in our study social class was
similar both in cocaine users and in control subjects, all living in
the same area near the hospital.
In conclusion, our findings show the proatherosclerotic
effects of cocaine in humans. Myocardial infarction with normal
coronary arteries is uncommon, whereas significant and severe
coronary atherosclerosis, with increased incidence of multives-
sel disease, is frequent in young regular cocaine users with
acute MI.
Figure 1. Incidence of significant lesions. Open bars  cocaine; solid
bars  control. Pt  patient.
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Association Between Right Bundle Branch Block and Impaired Myocardial Tissue-Level
Reperfusion in Patients With Acute Myocardial Infarction
To the Editor: The new onset of right bundle branch block
(RBBB) was identified as a potent predictor of adverse outcome
in patients with ST-segment elevation myocardial infarction
(STEMI) in the thrombolytic era (1). In the primary percuta-
neous coronary intervention (PCI) era (2), well-preserved
myocardial tissue-level reperfusion has been shown to be a
prerequisite for improved clinical outcome in patients with
STEMI (3,4).
In the present study, we evaluated the clinical benefit of PCI in
patients with a first anterior STEMI complicated by RBBB and
investigated the association between RBBB and impaired myocar-
dial tissue-level reperfusion in those patients in whom PCI
provided little benefit.
A total of 105 consecutive patients with a first anterior STEMI
due to proximal occlusion of the left anterior descending coronary
artery were divided into two groups according to the presence or
absence of RBBB on admission. The RBBB was considered new if
it was not apparent on a previous electrocardiogram or if no
previous tracing was available (1).
Culprit epicardial coronary flow was evaluated by the Throm-
bolysis In Myocardial Infarction (TIMI) flow grade with an
assessment of Rentrop collateral grade. Successful PCI was defined
as adequate restoration of coronary artery patency (TIMI flow
grade 2 or 3) and 50% postprocedural diameter stenosis in the
culprit. To evaluate myocardial tissue-level reperfusion, TIMI
myocardial perfusion (TMP) grade (5) and resolution of the sum
of ST-segment elevation in leads I, aVL, and V1 through V6 after
PCI (6) were analyzed by two observers blinded to the patient’s
identity. Impaired myocardial tissue-level reperfusion was defined
by the presence of both a TMP grade of 3 and resolution of the
sum of ST-segment elevation of 50% after coronary angioplasty
(4). With a two-compartment model, enzymatic infarct size was
defined as the area under the curve of plasma levels of creatine
kinase-myocardial band fraction, which were measured every 4 h
during the first 24 h after admission. During a mean follow-up
period of 22  14 months after discharge, the incidence of major
adverse cardiovascular events (MACE) such as death from cardiac
diseases, myocardial infarction, hospital stay for heart failure, and
ischemia-driven target-vessel revascularization were obtained by
either a review of the hospital records or telephone contact with
the patients.
Continuous variables are presented as mean  SD, and com-
parisons were made by an unpaired t test or a Mann-Whitney U
test in accordance with data distribution. Categorical variables
were compared by a chi-square test. A logistic-regression analysis
with calculation of odds ratio was performed to evaluate the
independent relations of selected variables to impaired myocardial
tissue-level reperfusion. The p values were determined by two-
tailed tests.
A total of 24 patients (23%) showed RBBB on admission.
Baseline clinical and angiographic characteristics according to the
presence or absence of RBBB are shown in Table 1. An increased
ratio of patients with diabetes mellitus and Killip III or IV was
observed in the RBBB group. Culprit coronary lesions were
recanalized in all patients, and the incidence of a final TIMI flow
grade 0 or 1 was three patients with RBBB and four without (13%
vs. 5%, p  0.399). Calculated enzymatic infarct size was greater
in patients with RBBB than in those without (10,350 6,557 IU/l
vs. 7,262 5,240 IU/l, p 0.025). A50% resolution in the sum
of ST-segment elevation was obtained in only 4 patients with
RBBB as compared with 52 without (17% vs. 64%, p  0.001).
Seven patients with RBBB and nine without showed a paradoxical
ST-segment elevation after PCI (29% vs. 11%, p  0.031). A
TMP grade 3 was achieved in 9 patients with RBBB, in contrast
to 62 without (38% vs. 77%, p  0.001) (Fig. 1A). Impaired
myocardial tissue-level reperfusion, defined by the presence of both
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